Clinical trial Recruiting at 1 site Observational Ages 18 to 50 Men only

Assessing testicular function and semen quality in young male cancer survivors

Official title: Effect of Cancer Treatment on Testicular Function and Semen Quality in Male Childhood and Adolescent Cancer Survivors

Run by The University of Hong Kong · NCT06587477 · Data updated 2026-11-12

This study is trying to see how well the testicles are working and the quality of semen in young men who survived cancer as kids or teens, compared to men their age who didn't have cancer.

More Cancer, Treatment-Related trials

Quick facts

Study typeObservational
Ages18 Years to 50 Years
SexMen only
Enrollment200 (estimated)
SponsorThe University of Hong Kong
Academic / other
Drugs / interventionschemotherapy
Locations1 site (Hong Kong)
StatusRecruiting
StartedJanuary 16, 2023
Main results expectedDecember 31, 2027
Study endsJune 30, 2028
Registry record updatedSeptember 19, 2024
Trial IDNCT06587477 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are men aged 18 to 50 who received cancer treatment before age 18 and have been in remission for at least two years.

Probably not a fit

Patients who are unable to provide semen samples or have specific medical conditions such as testicular cancer or are on testosterone replacement therapy may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study aims to evaluate the testicular function and semen quality in male survivors of childhood and adolescent cancer who are now adults. Participants will include men aged 18 to 50 who received chemotherapy or radiotherapy for cancer diagnosed before age 18 and have been in remission for at least two years. The study will compare their testicular function with that of age-matched controls from a premarital check-up clinic. Data will be collected through hormonal profiling, semen analysis, and questionnaires.

Why it matters

Potential benefit: If successful, this study could provide critical insights for improving pre-treatment counseling and post-treatment care for young male cancer survivors.

How similar studies have gone: Other studies have shown success in assessing long-term effects of cancer treatment on reproductive health, making this approach both relevant and necessary.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Men who have received chemotherapy and/ or radiotherapy for cancer diagnosed when they were \< 18 years old.
* \> 18 years old to 50 years old
* Cancer in remission for at least 2 years

Exclusion Criteria:

* Unable to ejaculate by masturbation to provide semen samples
* Cryptorchidism, testicular cancer, history of vasectomy
* On testosterone replacement therapy
* Refusal to join the study

Where it's running

  • Queen Mary Hospital
    Hong Kong, China
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.